Clindamycin Hydrochloride

盐酸克林霉素

Report date: 2026/02/10 20:00:22
NME

Base Information

Drug NameClindamycin Hydrochloride
Drug Alias NameClindamicina Hydrochloride盐酸氯洁霉素Cindamycine Hydrochloride盐酸氯林可霉素克林霉素盐酸盐 +[17] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action50S ribosomal subunit inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsComplicated Skin and Soft Tissue InfectionsSusceptible anaerobic bacteria infectionAcne Vulgaris +[21] 
Global Approved IndicationsComplicated Skin and Soft Tissue InfectionsSusceptible anaerobic bacteria infectionAcne Vulgaris +[17] 
Approved Indications in ChinaSusceptible anaerobic bacteria infectionGram-Positive Bacterial Infections
Original Approved Country/TerritoryN/A
Original Approved Date1969/01/01
Country/TerritoryUnited StatesGabonMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesPfizer IncPfizer Japan IncCipla Ltd +[4] 
Inactive CompaniesCairo UniversitySanaria IncTaro Pharmaceuticals Usa Inc +[4] 
Active IndicationsComplicated Skin and Soft Tissue InfectionsSusceptible anaerobic bacteria infectionAcne Vulgaris +[17] 
Inactive IndicationsHypotension, OrthostaticSurgical Wound InfectionMalaria, Falciparum +[4] 

Other Information

ATC CodeD10AF01G01AA10J01FF01
Related LinksWikipediaDrugBankKEGG